Raynaud’s Disease Life Insurance in 2026: Controlled vs Uncontrolled Rates

Written by: Joshua Wahls, founder of Insurance By Heroes.

Reviewed by: Joshua Wahls, licensed insurance producer, NPN 19191959.

Last reviewed: May 6, 2026

Our process: We review life insurance content for accuracy, state availability, carrier fit, underwriting context, and consumer clarity. See our Editorial Policy, Licensing, and Advertising Disclosure.

Raynaud’s Disease Life Insurance in 2026: Controlled vs Uncontrolled Rates

Bottom Line. If you have controlled Raynaud’s disease and want life insurance, approval is very likely. Most applicants with stable, well managed Raynaud’s qualify at standard or mildly rated terms. Your disease activity level, any associated autoimmune conditions, and treatment history will determine your final rate class.

Yes, You Can Get Life Insurance with Raynaud’s Disease

A Raynaud’s diagnosis does not mean you will be declined for life insurance. Carriers see this condition regularly, and the vast majority of applicants with controlled Raynaud’s walk away with an approved policy. You may pay a bit more than someone without the condition, but the difference is often smaller than people expect.

The real question is not whether you can get coverage. It is how to position your application so you land the best possible rate.

Why Raynaud’s Disease Affects Your Life Insurance Rate

From an underwriter’s perspective, Raynaud’s disease raises a specific concern. The condition involves episodes of vasospasm, where blood flow to the fingers, toes, or other extremities temporarily decreases. By itself, primary Raynaud’s (with no underlying autoimmune disease) is considered a mild condition.

What changes the picture is whether Raynaud’s is primary or secondary. Secondary Raynaud’s is linked to autoimmune conditions like lupus, scleroderma, or rheumatoid arthritis. When that connection exists, the underwriter shifts focus to the underlying autoimmune disease and its severity. Organ involvement, flare frequency, and the type of medications you take all become central factors.

What Underwriters Actually Evaluate

When your application lands on an underwriter’s desk, they look at a specific set of factors. Here is what moves the needle.

  • Your specific diagnosis. Primary Raynaud’s with no associated autoimmune disease is evaluated very differently from secondary Raynaud’s tied to scleroderma or lupus.
  • Disease activity and control status. Remission or low activity is a major positive factor. Active disease with frequent flares pushes ratings higher.
  • Current treatment and response. A single, stable medication regimen held for two or more years signals good control. Multiple medication switches suggest the disease is harder to manage.
  • Organ involvement. Skin and joint involvement only carries a significantly better prognosis than kidney, lung, or neurological involvement.
  • Time since diagnosis. A longer disease history with stable control is actually reassuring to underwriters. Someone who has managed Raynaud’s and any associated conditions for a decade with good outcomes presents a known, predictable risk.
  • Most recent specialist evaluation. A rheumatology visit within the past 12 months showing stability strengthens your file considerably.

Raynaud’s Disease Controlled: What to Expect

If your Raynaud’s is well controlled, particularly primary Raynaud’s with no underlying autoimmune condition, you may qualify at standard rates or a mild table rating (Table 1 to 2). That translates to real, affordable numbers.

Here is how table ratings work in plain terms. Each “table” adds roughly 25% to the standard premium. So Table 1 means 25% above standard, Table 2 means 50% above, and Table 4 means double the standard rate. On a $500,000, 20 year term policy for a 40 year old, standard rates might run about $45 per month. A Table 2 rating would bring that to roughly $65 per month. That is about the cost of a streaming subscription and a couple of coffees each week.

For mild controlled Raynaud’s, especially with conditions like controlled Hashimoto’s or mild psoriasis alongside it, offers often land at standard to Table 1 or 2. Moderate cases in remission, like Raynaud’s secondary to stable rheumatoid arthritis on biologic therapy, typically see Table 2 to 4 outcomes.

Raynaud’s Disease Uncontrolled: A Different Picture

When Raynaud’s disease is uncontrolled, the underwriting outlook shifts. Active disease with frequent vasospastic episodes, digital ulcers, or progression of an underlying autoimmune condition raises significant concerns.

Uncontrolled Raynaud’s often signals that an associated autoimmune disease is not well managed either. Underwriters will flag several warning signs.

  • Active disease with frequent flares despite treatment
  • Multiple medication changes suggesting poor disease control
  • Ongoing use of high dose steroids (more than 20mg of prednisone daily)
  • Recent hospitalization or emergency room visits
  • Significant functional limitations affecting work capacity
  • Secondary infections tied to immunosuppressive therapy

For someone with uncontrolled Raynaud’s tied to a complex autoimmune condition, ratings could land at Table 6 to 8 or higher. In severe progressive cases, like scleroderma with lung involvement, some carriers may postpone or decline the application.

But here is something many people do not realize. “Uncontrolled” is not necessarily a permanent label. If you can achieve stability on your current treatment, wait until you have maintained remission or low disease activity for at least one to two years, and then apply, the outcome can improve dramatically. The worst move is applying during an active flare.

Why an Independent Agency Makes a Real Difference

This is where your choice of agency matters more than almost anything else. Different insurance carriers can rate the exact same health profile two to four tables apart. One company’s Table 4 is another company’s Table 2 for identical medical records. On a $500,000 policy, that gap could mean hundreds of dollars per year in premium savings.

A captive agent who works for a single carrier can only offer you that one company’s rating. If their underwriting guidelines are strict on autoimmune conditions, you are stuck with a higher rate or a decline, never knowing a better offer existed elsewhere.

At Insurance By Heroes, we were founded by a former first responder and military spouse, and every member of our team comes from a background in public service. That service first mindset means we treat every client’s application with the same care and urgency we brought to protecting our communities. We work with many different carriers, which lets us match your specific health profile to the companies most likely to offer favorable terms. For conditions like Raynaud’s, where carrier guidelines vary widely, this independent approach can save you real money.

Positioning Yourself for the Best Possible Outcome

A few steps before applying can make a measurable difference in your final rate.

  • Get a current specialist evaluation. A rheumatology report from within the past 12 months showing stable or low disease activity is one of the strongest documents you can provide.
  • Gather your medication history. Have a clear list of current medications, dosages, and how long you have been on each one. Long term stability on a single regimen is a positive signal.
  • Document your disease activity. If you have been in remission or low activity for two or more years, make sure that is clearly stated in your medical records.
  • Do not hide biologic medications. Many applicants assume that drugs like Humira or Enbrel will trigger an automatic decline. They will not. Underwriters understand these are standard care for autoimmune conditions. What matters is whether the medication is controlling your disease effectively.
  • Address any associated conditions. If your Raynaud’s is secondary to another autoimmune disease, be specific. “Autoimmune disease” is too vague. The difference between skin only lupus and lupus with kidney involvement changes the entire underwriting outcome.

Common Mistakes That Cost You Money

One of the most expensive errors is being vague on your application. Listing “autoimmune condition” without specifying the exact diagnosis forces underwriters to assume the worst. Similarly, omitting details about organ involvement can backfire. Skin and joint involvement only carries a much better prognosis than multi organ disease, and if you do not clarify, the underwriter may assign a higher rating than necessary.

Another costly mistake is applying during an active flare or shortly after a hospitalization. If you can wait for stability, even a few months of documented remission can shift your offer by one or two table ratings. That patience can save you thousands over the life of a policy.

Some people also assume the rate is simply “too expensive” and never apply. But consider this. Even at a Table 4 rating, a $500,000 term policy for a 40 year old might cost around $90 per month. That is roughly $3 per day to make sure your family is protected. And with an independent agency shopping multiple carriers on your behalf, your actual offer could come in lower than you expect.

FAQ

How much more does life insurance cost with controlled Raynaud’s disease?

For primary Raynaud’s that is well controlled, many applicants qualify at standard rates or Table 1 to 2. On a $500,000, 20 year term policy, that could mean paying $45 to $65 per month instead of the roughly $45 standard rate. The exact premium depends on your overall health, the presence of any associated autoimmune conditions, and which carrier you apply with.

Can I get approved for life insurance with uncontrolled Raynaud’s disease?

Approval is still possible in many cases, though ratings will be higher. Uncontrolled Raynaud’s tied to an active autoimmune condition may result in Table 6 to 8 ratings or a postponement. Working toward disease stability and documenting improvement over one to two years before applying can significantly improve your outcome.

Should I wait to apply until my Raynaud’s is better controlled?

If you are in an active flare or recently hospitalized, waiting for documented stability is generally wise. However, do not wait indefinitely. Getting older also increases premiums, and potential complications could worsen your profile. The ideal time is once you have maintained low disease activity or remission for at least one to two years on a stable treatment plan.

Do biologic medications like Humira affect my life insurance application?

Biologic therapies are not automatic disqualifiers. Underwriters recognize that drugs like Humira, Enbrel, and Remicade are standard treatments for many autoimmune conditions. What matters is whether the medication is effectively controlling your disease. Stable, long term use of a biologic with good response is actually a positive factor in underwriting.

Getting the right life insurance offer with Raynaud’s disease comes down to preparation, timing, and working with an agency that knows how to match your specific situation to the right carrier. Our team at Insurance By Heroes is ready to help you find the most competitive rate available. Reach out for a free quote comparison and let us put our experience to work for your family.

Popular Guides from Insurance By Heroes

Guaranteed Universal Life Rates: 2026 Guide

Lock in a death benefit for life with level premiums.

No-Exam Life Insurance Over 50

Skip the medical exam. Real options after 50.

Burial Insurance: The Complete Guide

Coverage designed for final expenses, most health histories accepted.

Royal Neighbors Life Insurance Review

A favorite for final expense coverage. Rates and verdict.

Best Life Insurance Over 80

Real options that still make sense at 80 and beyond.

Get an Instant Estimate

See your rate in under a minute. No obligation.

Not sure which option is right for you?

Talk to a licensed agent who can help — free, no obligation, no sales pressure.
Schedule a Call
Free · No obligation · No sales pressure
See Instant Quotes Schedule a Call